W. M. Liu, H. W. Hethcote, L. , and S. A. , Dynamical behavior of epidemiological models with nonlinear incidence rates, Journal of Mathematical Biology, vol.31, issue.4, pp.359-380, 1987.
DOI : 10.1007/978-1-4612-6374-6

S. E. Luria and M. Delbruck, Mutations of bacteria from virus sensitivity to virus 562 resistance, Genetics, vol.28, pp.491-511, 1943.

M. Lusiak-szelachowska, M. Zaczek, B. Weber-dabrowska, R. Miedzybrodzki, and M. Klak, , p.564

W. Fortuna, S. Letkiewicz, P. Rogoz, K. Szufnarowski, and E. Jonczyk-matysiak, , 2014.

, Phage neutralization by sera of patients receiving phage therapy, Viral Immunol, vol.27, pp.295-304

M. Lusiak-szelachowska, M. Zaczek, B. Weber-dabrowska, and R. Miedzybrodzki, , 2016.

, Antiphage activity of sera during phage therapy in relation to its outcome. Future microbiology, p.569

J. Majewska, W. Beta, D. Lecion, K. Hodyra-stefaniak, and A. Klopot,

P. Miernikiewicz, A. Piotrowicz, J. Ciekot, and B. Owczarek, Oral application of T4 571, 2015.

, phage induces weak antibody production in the gut and in the blood, Viruses, vol.7, pp.4783-4799

F. Mazurier, A. Fontanellas, S. Salesse, and L. Taine, , p.573

J. Peault, B. , D. Santo, J. P. De-verneuil, and H. , A novel immunodeficient mouse 574 model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous 575, 1999.

, cytokine administration for human hematopoietic stem cell engraftment, J Interferon Cytokine, vol.576

, Res, vol.19, pp.533-541

C. R. Merril, B. Biswas, R. Carlton, N. C. Jensen, G. J. Creed et al., , 1996.

, Long-circulating bacteriophage as antibacterial agents, Proc Natl Acad Sci U S A, vol.93, pp.3188-3192

J. R. Meyer, D. T. Dobias, J. S. Weitz, J. E. Barrick, R. T. Quick et al., , 2012.

, Repeatability and contingency in the evolution of a key innovation in phage lambda, Science, vol.581, issue.335, pp.428-432

M. K. Mirzaei, M. , and C. F. , M??nage ?? trois in the human gut: interactions between host, bacteria and phages, Nature Reviews Microbiology, vol.102, issue.7, 2017.
DOI : 10.1073/pnas.0504062102

D. T. Moir, D. Ming, T. Opperman, H. P. Schweizer, and T. L. Bowlin, Gyrase Inhibitors and Other DNA-Damaging Agents, Journal of Biomolecular Screening, vol.45, issue.56, pp.855-864, 2007.
DOI : 10.1128/AAC.45.1.105-116.2001

A. Munder, F. Wolbeling, J. Klockgether, L. Wiehlmann, and B. Tummler, In vivo 588 imaging of bioluminescent Pseudomonas aeruginosa in an acute murine airway infection model, p.589, 2014.

, Pathog Dis, vol.72, pp.74-77

J. L. Murray, T. Kwon, E. M. Marcotte, and M. Whiteley, Intrinsic Antimicrobial 591, 2015.

, Resistance Determinants in the Superbug Pseudomonas aeruginosa, pp.1603-01615

P. E. Newburger, D. , and D. C. , Evaluation and Management of Patients With Isolated Neutropenia, Seminars in Hematology, vol.50, issue.3, pp.198-206, 2013.
DOI : 10.1053/j.seminhematol.2013.06.010

R. Pabary, C. Singh, S. Morales, A. Bush, K. Alshafi et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.60, issue.2, pp.744-751, 2016.
DOI : 10.1128/AAC.01426-15

J. Reutershan, A. Basit, E. V. Galkina, and K. Ley, , p.598, 2005.

, neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury, Am J, p.599

, Physiol Lung Cell Mol Physiol, vol.289, pp.807-815

D. D. Rhoads, R. D. Wolcott, M. A. Kuskowski, B. M. Wolcott, L. S. Ward et al., Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial, Journal of Wound Care, vol.57, issue.6, pp.237-238, 2009.
DOI : 10.1016/S0741-5214(99)70076-5

D. R. Roach and L. Debarbieux, Phage therapy: awakening a sleeping giant, Emerging Topics in Life Sciences, vol.1, issue.1, pp.93-103, 2017.
DOI : 10.1042/ETLS20170002

M. Roy and M. Pascual, On representing network heterogeneities in the incidence rate of simple epidemic models, Ecological Complexity, vol.3, issue.1, pp.80-90, 2006.
DOI : 10.1016/j.ecocom.2005.09.001

G. P. Salmond and P. C. Fineran, A century of the phage: past, present and future, Nature Reviews Microbiology, vol.494, issue.12, p.608, 2015.
DOI : 10.1038/nature11927

, Rev Microbiol, vol.13, pp.777-786

E. L. Salsgiver, A. K. Fink, E. A. Knapp, J. J. Lipuma, and K. N. Olivier, , p.610

L. Saiman, Changing Epidemiology of the Respiratory Bacteriology of Patients With, p.611, 2016.

, Cystic Fibrosis. Chest, vol.149, pp.390-400

S. A. Sarker, B. Berger, Y. Deng, S. Kieser, and F. Foata, , p.613

S. Huq and P. K. Bardhan, Oral application of Escherichia coli bacteriophage: safety 614 tests in healthy and diarrheal children from Bangladesh, Environ Microbiol, p.615, 2016.

S. A. Sarker, S. Sultana, G. Reuteler, D. Moine, P. Descombes et al., , p.616

S. Mccallin, C. Ngom-bru, and T. Neville, Oral Phage Therapy of Acute Bacterial, p.617, 2016.

, Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh, p.618

, EBioMedicine, vol.4, pp.124-137

S. J. Skerrett, H. D. Liggitt, A. M. Hajjar, W. , and C. B. , Cutting Edge: Myeloid Differentiation Factor 88 Is Essential for Pulmonary Host Defense against Pseudomonas aeruginosa but Not Staphylococcus aureus, The Journal of Immunology, vol.172, issue.6, pp.3377-3381, 2004.
DOI : 10.4049/jimmunol.172.6.3377

URL : http://www.jimmunol.org/content/172/6/3377.full.pdf

H. W. Smith and M. B. Huggins, Successful treatment of experimental Escherichia coli 623 infections in mice using phage: its general superiority over antibiotics, J Gen Microbiol, vol.128, issue.624, pp.307-318, 1982.

S. Stanojevic, V. Waters, J. L. Mathew, L. Taylor, and F. And-ratjen, , p.626, 2014.

, inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis, p.627

, Cyst Fibros, vol.13, pp.172-178

D. Vandenheuvel, R. Lavigne, and H. Brussow, Bacteriophage Therapy, p.629, 2015.

, Formulation Strategies and Human Clinical Trials, Annu Rev Virol, vol.2, pp.599-618

N. Warner and G. Nunez, MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction, The Journal of Immunology, vol.190, issue.1, pp.3-4, 2013.
DOI : 10.4049/jimmunol.1203103

E. R. Weibel, Morphometry of the human lung, 1963.

J. S. Weitz, Quantitative viral ecology: Dynamics of viruses and their microbial hosts 634, 2015.

J. S. Weitz and J. Dushoff, Alternative stable states in host???phage dynamics, Theoretical 636 Ecology, pp.13-19, 2008.
DOI : 10.1007/978-1-4684-5409-3_1

Z. Zhang, J. P. Louboutin, D. J. Weiner, J. B. Goldberg, W. et al., Human 638, 2005.

, airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by 639

, Toll-like receptor 5, Infect Immun, vol.73, pp.7151-7160